News | April 06, 2022
ENTOD Pharma bullish on Macushield sales
Macushield tablets assist with age-related macular degeneration, diabetic retinopathy and improves overall vision
Macushield tablets assist with age-related macular degeneration, diabetic retinopathy and improves overall vision
R&D investment up 11.7% to 4.1 billion EUR in 2021 (20.0% of net sales)
Through this new set-up, the company intends to make available, affordable high-quality medical diagnostic imaging equipment across Tier 2, 3, and 4 towns in India
Yescarta is First CAR T-cell therapy to receive NCCN treatment guideline category 1 recommendation --
It is one of the 15 medical device manufacturers approved under the government’s PLI scheme
An estimated 21 million American women experience BV
One of the most advanced cancer care centres in the state of Odisha, it is equipped with the latest technology and a highly experienced multi-disciplinary team of oncologists
Technology Development Board supports commercialisation of Metal Injection Molding of implants
50 µg dose approved for all adults over 50 years of age and immunocompromised adults over 18 years of age
It celebrated its 100th session as LPC-100 in association with Mundial Pharma
Subscribe To Our Newsletter & Stay Updated
